Abstract
4/2012
vol. 11
Original paper
Higher premenopausal serum androgen levels and higher postmenopausal estrogen levels in women with endometrial hyperplasia
Przegląd Menopauzalny 2012; 4: 309–318
Online publish date: 2012/09/08
Objectives: To assess the hormonal status of individual groups of endometrial pathology. Prospective observational study.
Material and methods: 100 peri- and postmenopausal women with abnormal uterine bleedings and/or abnormal endometrium. The population of women was divided into four groups according to hysteroscopic examination, confirmed by histopathology (non-atypical endometrial hyperplasia, polyp, cancer, controls). The levels of selected hormones, growth factors and binding proteins were marked.
Results: Serum DHEAS, estradiol and estrone levels are significantly higher in women with hyperplasia in comparison with the control group (p < 0.05). Higher concentrations of serum DHEAS and testosterone occur more frequently in premenopausal women with hyperplasia (p < 0.01 and p < 0.05), whereas high concentrations of estradiol and estrone play an important role in the case of postmenopausal hyperplasia (p < 0.05). Concentration of estrone can be a predictor of endometrial hyperplasia. This type of pathology occurred significantly more frequently in patients with serum estrone concentration ≥ 174 pg/ml. High serum levels of IGFBP-3 (> 5.58 ng/ml) occurred in 62.5% of women with endometrial hyperplasia, which suggests possible participation of this factor in the pathogenesis of hyperplastic changes of the endometrium.
Conclusion: Higher serum androgen levels (DHEAS, testosterone) in premenopausal women with hyperplasia than in control group suggest possible participation of androgens in the pathogenesis of premenopausal hyperplasia, similarly to higher concentrations of estrogens (estradiol, estrone) in postmenopausal women.
Material and methods: 100 peri- and postmenopausal women with abnormal uterine bleedings and/or abnormal endometrium. The population of women was divided into four groups according to hysteroscopic examination, confirmed by histopathology (non-atypical endometrial hyperplasia, polyp, cancer, controls). The levels of selected hormones, growth factors and binding proteins were marked.
Results: Serum DHEAS, estradiol and estrone levels are significantly higher in women with hyperplasia in comparison with the control group (p < 0.05). Higher concentrations of serum DHEAS and testosterone occur more frequently in premenopausal women with hyperplasia (p < 0.01 and p < 0.05), whereas high concentrations of estradiol and estrone play an important role in the case of postmenopausal hyperplasia (p < 0.05). Concentration of estrone can be a predictor of endometrial hyperplasia. This type of pathology occurred significantly more frequently in patients with serum estrone concentration ≥ 174 pg/ml. High serum levels of IGFBP-3 (> 5.58 ng/ml) occurred in 62.5% of women with endometrial hyperplasia, which suggests possible participation of this factor in the pathogenesis of hyperplastic changes of the endometrium.
Conclusion: Higher serum androgen levels (DHEAS, testosterone) in premenopausal women with hyperplasia than in control group suggest possible participation of androgens in the pathogenesis of premenopausal hyperplasia, similarly to higher concentrations of estrogens (estradiol, estrone) in postmenopausal women.
Keywords
endometrial hyperplasia, estrogens, androgens, menopause
Coverage in
Indexed in
Integrated with
Editorial Policies
